home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

IL-7 Is Critical For Maintaining A Healthy Balance Of Naïve And Memory T Cells

 
  October, 26 2000 1:46
your information resource in human molecular genetics
 
     
Balancing naïvete with experience

Before killer T cells (usually bearing the CD8 marker) are exposed to foreign pathogens, they are considered "naïve." After fighting an infection a population called "memory" CD8 T cells lingers and provides a much faster response should the pathogen resurface. A balance of naïve and memory cells must be maintained in the body so that naïve cells can fight new infections and memory cells can to react to old foes. How the naïve and memory CD8 T cell pools are regulated is poorly understood, although recent evidence suggests immune modulators, called cytokines, may play a role in maintaining levels of memory cells.

In the November issue of Nature Immunology (Vol. 1, No. 5), scientists from Minneapolis, Minnesota, show that the cytokine interleukin 7 (IL-7) plays multiple roles in maintaining the right numbers of naïve and memory T cells. IL-7 was required to regulate the survival of naïve T cells in the host. It was also needed for the generation of memory CD8+ T cells. In addition, the levels of CD8+ memory T cells in the T cell pool were partially dependent on IL-7. Thus, IL-7 is critical for maintaining a healthy balance of naïve and memory T cells in the body.

Contact Information:

Leo Lefrancois
University of Connecticut
Health Center
School of Medicine
Department of Medicine
Division of Rheumatic Diseases
263 Farmington Avenue
Farmington, CT 06030-1310
Tel: 860-679-3242
Fax: 860-679-1287
Email: llefranc@neuron.uchc.edu

(C) Nature Immunology press release.



Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.